Bluebird Bio Withdrawal Raises Gene Therapy Doubts in Europe
Last month, the US firm bluebird bio abandoned the sale of its gene therapy Zynteglo…
04/05/2021 - 5 minutes
Germany
ADVERTISEMENT
Do you want to remove this advert? Become a member!
Innate Immunity in Cancer Gains Recognition with Affimed’s €1.8B Deal
Last week’s €1.75B deal between the German biotech Affimed and Swiss giant Roivant backs up…
16/11/2020 - 3 minutes
Evonik and Beiersdorf Team Up to Turn CO₂ into Skin Care Products
The German companies Evonik and Beiersdorf will work together on a joint research project to…
25/05/2020 - 2 minutes
Synthetic Biology Could Lead to Clean Energy Using Light and Carbon Dioxide
Researchers in Germany and France have combined synthetic biology with microfluidics to create artificial photosynthetic…
15/05/2020 - 3 minutes
This Startup is Developing Anti-Aging Antibodies
The Heidelberg-based startup Velabs Therapeutics aims to make anti-aging drugs that selectively destroy ‘aged’ cells…
21/02/2020 - 4 minutes
Cardior Pharmaceuticals’ Heart Failure Drug Shows Curative Potential
German biotech company Cardior Pharmaceuticals’ candidate heart failure drug has the potential to stop the…
01/02/2020 - 3 minutes
German Biotech Raises €11M to Regenerate Liver Damage
Biotech company HepaRegeniX has raised a Series B round that will allow its first…
21/01/2020 - 2 minutes
International Collaboration on Brink of Resurrecting Northern White Rhinos
An international collaboration called BioRescue has taken a step forward in bringing back the Northern…
17/01/2020 - 3 minutes
BioNTech’s RNA-Boosted CAR T-Cell Therapy Shrinks Tumors in Mice
A CAR T-cell therapy amplified by RNA technology, developed by BioNTech, has shown preclinical potential…
06/01/2020 - 2 minutes
German Startup Raises €4M Seed Round to Make Dairy Cheese Without Milk
Berlin-based startup Legendairy Foods has raised €4M to develop cheese and other dairy products…
20/12/2019 - 1 minute
Update: Cancer Immunotherapy Biotech Files for Insolvency
Update (06/12/2019): Following the phase III failure of its immunotherapy drug for colorectal cancer in…
06/12/2019 - 2 minutes
German Biotech Raises €7M Series A to Treat Acute Heart Failure
4TEEN4 Pharmaceuticals has raised a Series A round of €6.9M to fuel the development of…
05/12/2019 - 2 minutes
